Abstract: Hydrogen sulfide (H2S) levels in plasma are useful in diagnosing cardiovascular disease. The ratio of H2S to NO in plasma is useful in diagnosing peripheral artery disease.
Type:
Application
Filed:
October 22, 2013
Publication date:
August 20, 2015
Applicant:
LSU System Office
Inventors:
Christopher KEVIL, Elvis A. PETER, Xinggui SHEN
Abstract: A method to measure all relevant biologic hydrogen sulfide pools, namely free hydrogen sulfide, acid-labile sulfide, and bound sulfane sulfur, has been developed. This new method involves selective liberation, trapping and derivatization of labile hydrogen sulfide. The total labile sulfide, including the contribution of the bound sulfane sulfur pool, the acid-labile pool, and free H2S, was measured by incubating the sample with a reducing agent, TCEP (Tris(2-carboxyethyl)phosphine hydrochloride), to reduce disulfide bonds in an acid solution. This method was used to measure the three sulfide pools in blood samples from mice and from humans. This method can be used for research, environmental, and clinical diagnostic purposes in determining hydrogen sulfide bioavailability in biological or other samples.
Type:
Application
Filed:
March 14, 2013
Publication date:
February 26, 2015
Applicant:
LSU System Office
Inventors:
Christopher G. Kevil, Xinggui Shen, Elvis A. Peter
Abstract: Several new peptides have been developed that show effectiveness as vaccines against candidiasis and other fungal diseases. A new conjugate vaccine of a ?-mannotriose linked to a fungal peptide linked to tetanus toxin has been shown to be effective as a vaccine with or without use of an adjuvant. In addition, a monoclonal antibody has been identified that offers protection from a Candida infection.
Type:
Application
Filed:
April 20, 2012
Publication date:
February 6, 2014
Applicant:
LSU Systems Office
Inventors:
Jim E. Cutler, Hong Xin, David R. Bundle, Sebastian Dziadek